HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Mustafa Mohammadi Selected Research

Cyclosporine (Ciclosporin)

10/2017Combined postconditioning with ischemia and cyclosporine-A restore oxidative stress and histopathological changes in reperfusion injury of diabetic myocardium.
1/2014Inhibition of mitochondrial permeability transition pore restores the cardioprotection by postconditioning in diabetic hearts.
6/2012The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Mustafa Mohammadi Research Topics

Disease

6Ischemia
06/2018 - 06/2012
6Reperfusion Injury
10/2017 - 12/2012
4Myocardial Ischemia (Ischemic Heart Diseases)
06/2018 - 12/2012
3Myocardial Reperfusion Injury
06/2018 - 12/2012
2Atherosclerosis
01/2017 - 01/2006
2Infarction (Infarctions)
01/2014 - 06/2012
1Cardiovascular Diseases (Cardiovascular Disease)
07/2017
1Hypoxia (Hypoxemia)
01/2017
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
10/2016
1ST Elevation Myocardial Infarction
01/2016
1Wounds and Injuries (Trauma)
04/2015
1Congenital Abnormalities (Deformity)
04/2015
1Inflammation (Inflammations)
01/2014
1Myocardial Infarction
06/2013
1Cardiotoxicity
06/2013
1Hyperglycemia
12/2012
1Weight Loss (Weight Reduction)
12/2012

Drug/Important Bio-Agent (IBA)

4AntioxidantsIBA
01/2016 - 12/2012
3Cyclosporine (Ciclosporin)FDA LinkGeneric
10/2017 - 06/2012
2Streptozocin (Streptozotocin)FDA Link
10/2017 - 10/2016
2CholesterolIBA
01/2017 - 01/2006
2troxerutinIBA
10/2015 - 04/2015
2DiosgeninIBA
06/2014 - 06/2013
2triphenyltetrazoliumIBA
01/2014 - 06/2012
1VildagliptinIBA
06/2018
1crocinIBA
07/2017
1Vasoconstrictor AgentsIBA
01/2017
1Epinephrine (Adrenaline)FDA LinkGeneric
01/2017
1Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2017
1ReninIBA
01/2017
1Proteins (Proteins, Gene)FDA Link
10/2015
1LipidsIBA
04/2015
1Glucose (Dextrose)FDA LinkGeneric
04/2015
1KATP ChannelsIBA
06/2014
1Interleukin-6 (Interleukin 6)IBA
06/2014
1mitochondrial K(ATP) channelIBA
06/2014
1PotassiumIBA
06/2014
1Adenosine Triphosphate (ATP)IBA
06/2014
1Mitochondrial Permeability Transition PoreIBA
01/2014
11- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
01/2014
1Isoproterenol (Isoprenaline)FDA LinkGeneric
06/2013
1SolutionsIBA
12/2012
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
12/2012
1Ethanol (Ethyl Alcohol)IBA
12/2012
1NitratesIBA
12/2012
1NitritesIBA
12/2012
1Glutathione (Reduced Glutathione)IBA
12/2012
1Superoxide DismutaseIBA
12/2012
1ResveratrolIBA
12/2012
1mebudipineIBA
12/2012
1EnzymesIBA
12/2012
11,4-dihydropyridine (dihydropyridine)IBA
12/2012
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2012

Therapy/Procedure

5Ischemic Postconditioning
06/2018 - 06/2012
1Ligation
06/2018
1Intraperitoneal Injections
10/2016
1Percutaneous Coronary Intervention
01/2016
1Caloric Restriction
01/2014